Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial

Julie R Brahmer; Delvys Rodríguez-Abreu; Andrew G Robinson; Rina Hui; Tibor Csőszi; Andrea Fülöp; Maya Gottfried; Nir Peled; Ali Tafreshi; Sinead Cuffe; Mary O'Brien; Suman Rao; Katsuyuki Hotta; Jin Zhang; Gregory M Lubiniecki; Anne C Deitz; Reshma Rangwala; Martin Reck

doi:10.1016/s1470-2045(17)30690-3

Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial

The Lancet Oncology ◽

10.1016/s1470-2045(17)30690-3 ◽

2017 ◽

Vol 18 (12) ◽

pp. 1600-1609 ◽

Cited By ~ 118

Author(s):

Julie R Brahmer ◽

Delvys Rodríguez-Abreu ◽

Andrew G Robinson ◽

Rina Hui ◽

Tibor Csőszi ◽

...

Keyword(s):

Quality Of Life ◽

Health Related Quality ◽

Open Label ◽

Phase 3 ◽

Open Label Phase ◽

Related Quality ◽

Health Related

Download Full-text

Bortezomib, thalidomide, and dexamethasone with or without daratumumab for transplantation-eligible patients with newly diagnosed multiple myeloma (CASSIOPEIA): health-related quality of life outcomes of a randomised, open-label, phase 3 trial

The Lancet Haematology ◽

10.1016/s2352-3026(20)30356-2 ◽

2020 ◽

Vol 7 (12) ◽

pp. e874-e883

Author(s):

Murielle Roussel ◽

Philippe Moreau ◽

Benjamin Hebraud ◽

Kamel Laribi ◽

Arnaud Jaccard ◽

...

Keyword(s):

Quality Of Life ◽

Newly Diagnosed ◽

Health Related Quality ◽

Life Outcomes ◽

Open Label ◽

Phase 3 ◽

Open Label Phase ◽

Related Quality ◽

Health Related

Download Full-text

Health-related quality of life and neurocognitive functioning with lomustine–temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trial

The Lancet Oncology ◽

10.1016/s1470-2045(19)30502-9 ◽

2019 ◽

Vol 20 (10) ◽

pp. 1444-1453 ◽

Cited By ~ 4

Author(s):

Johannes Weller ◽

Theophilos Tzaridis ◽

Frederic Mack ◽

Joachim Peter Steinbach ◽

Uwe Schlegel ◽

...

Keyword(s):

Quality Of Life ◽

Neurocognitive Functioning ◽

Newly Diagnosed ◽

Health Related Quality ◽

Open Label ◽

Phase 3 ◽

Open Label Phase ◽

Related Quality ◽

Health Related

Download Full-text

Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study

The Lancet Oncology ◽

10.1016/s1470-2045(16)30305-9 ◽

2016 ◽

Vol 17 (11) ◽

pp. 1533-1542 ◽

Cited By ~ 58

Author(s):

Jaap C Reijneveld ◽

Martin J B Taphoorn ◽

Corneel Coens ◽

Jacoline E C Bromberg ◽

Warren P Mason ◽

...

Keyword(s):

Quality Of Life ◽

High Risk ◽

Low Grade ◽

Health Related Quality ◽

Open Label ◽

Phase 3 ◽

Open Label Phase ◽

Related Quality ◽

Health Related

Download Full-text

Health-Related Quality of Life of Blinatumomab for Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia in a Randomized, Open-Label Phase 3 Study (TOWER): A Subgroup Analysis By Prior Allogeneic Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2018.12.073 ◽

2019 ◽

Vol 25 (3) ◽

pp. S8-S9

Author(s):

Xinke Zhang ◽

Andre C. Schuh ◽

Ze Cong ◽

Max S. Topp ◽

Zachary Zimmerman ◽

...

Keyword(s):

Lymphoblastic Leukemia ◽

Health Related Quality ◽

Cell Precursor ◽

Open Label ◽

Phase 3 ◽

Hematopoietic Stem ◽

Open Label Phase ◽

Related Quality ◽

Health Related

Download Full-text

3441 Randomized, open-label, multicenter, phase 3 study of eribulin versus dacarbazine in patients with leiomyosarcoma and adipocytic sarcoma: Health-related quality of life results

European Journal of Cancer ◽

10.1016/s0959-8049(16)31914-1 ◽

2015 ◽

Vol 51 ◽

pp. S702

Author(s):

H. Gelderblom ◽

J.Y. Blay ◽

D. D'Adamo ◽

S. Hudgens ◽

I. Kontoudis ◽

...

Keyword(s):

Quality Of Life ◽

Health Related Quality ◽

Open Label ◽

Phase 3 ◽

Multicenter Phase ◽

Related Quality ◽

Health Related

Download Full-text

Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial

The Lancet Oncology ◽

10.1016/s1470-2045(21)00064-4 ◽

2021 ◽

Author(s):

Thierry Andre ◽

Mayur Amonkar ◽

Josephine M Norquist ◽

Kai-Keen Shiu ◽

Tae Won Kim ◽

...

Keyword(s):

Quality Of Life ◽

Colorectal Cancer ◽

Mismatch Repair ◽

Health Related Quality ◽

First Line ◽

Open Label ◽

Phase 3 ◽

Related Quality ◽

Health Related

Download Full-text

Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, open-label, randomised trial

The Lancet Oncology ◽

10.1016/s1470-2045(15)00087-x ◽

2015 ◽

Vol 16 (13) ◽

pp. 1389-1398 ◽

Cited By ~ 122

Author(s):

Jean Jacques Grob ◽

Mayur M Amonkar ◽

Boguslawa Karaszewska ◽

Jacob Schachter ◽

Reinhard Dummer ◽

...

Keyword(s):

Quality Of Life ◽

Combination Therapy ◽

Randomised Trial ◽

Health Related Quality ◽

Open Label ◽

Phase 3 ◽

Related Quality ◽

Health Related

Download Full-text

Health-Related Quality of Life in Transplant Ineligible Newly Diagnosed Multiple Myeloma Patients Treated with Either Thalidomide or Lenalidomide-Based Regimen Until Progression (HOVON-87/NMSG18 Study): A Prospective, Open-Label, Multicenter, Randomized, Phase 3 Study

SSRN Electronic Journal ◽

10.2139/ssrn.3337896 ◽

2019 ◽

Author(s):

Lene Kongsgaard Nielsen ◽

Claudia Stege ◽

Birgit Lissenberg-Witte ◽

Bronno van der Holt ◽

Ulf-Henrik Mellqvist ◽

...

Keyword(s):

Quality Of Life ◽

Multiple Myeloma ◽

Newly Diagnosed ◽

Health Related Quality ◽

Open Label ◽

Phase 3 ◽

Related Quality ◽

Health Related

Download Full-text

Health-related quality of life in transplant ineligible newly diagnosed multiple myeloma patients treated with either thalidomide or lenalidomide-based regimen until progression: a prospective, open-label, multicenter, randomized, phase 3 study

Haematologica ◽

10.3324/haematol.2019.222299 ◽

2019 ◽

Vol 105 (6) ◽

pp. 1650-1659 ◽

Cited By ~ 2

Author(s):

Lene Kongsgaard Nielsen ◽

Claudia Stege ◽

Birgit Lissenberg-Witte ◽

Bronno van der Holt ◽

Ulf-Henrik Mellqvist ◽

...

Keyword(s):

Quality Of Life ◽

Multiple Myeloma ◽

Newly Diagnosed ◽

Health Related Quality ◽

Open Label ◽

Phase 3 ◽

Related Quality ◽

Health Related

Download Full-text

EFFECT OF DARATUMUMAB, BORTEZOMIB, CYCLOPHOSPHAMIDE, AND DEXAMETHASONE ON CARDIAC FUNCTION AND HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH NEWLY-DIAGNOSED AL AMYLOIDOSIS WITH CARDIAC INVOLVEMENT: RESULTS FROM THE PHASE 3 ANDROMEDA STUDY

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(21)04658-1 ◽

2021 ◽

Vol 77 (18) ◽

pp. 3304

Author(s):

Martha Grogan ◽

Mathew S. Maurer ◽

Ronald Witteles ◽

Divaya Bhutani ◽

Raymond L. Comenzo ◽

...

Keyword(s):

Quality Of Life ◽

Cardiac Function ◽

Cardiac Involvement ◽

Al Amyloidosis ◽

Newly Diagnosed ◽

Health Related Quality ◽

Phase 3 ◽

Related Quality ◽

Health Related

Download Full-text